Prof Renato D. Lopes (Duke University Medical Center, Durham, NC, US) discusses AUGUSTUS - an open-label, 2x2 factorial, RCT to evaluate the safety of apixaban versus VKA and aspirin versus placebo in patients with AF and ACS and/or PCI
Filmed on site at ACC 2019 by Radcliffe Cardiology
1. What is the AUGUSTUS trial and why was it needed?
2. Would you describe the study, design, patient population, and endpoints?
3. What were your findings?
4. How does this data compare to that from REDUAL PCI and PIONEER AF?
Videography: Josh Birch
Interviewer: Liam O'Neill